Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

Sequencio Therapeutics to Present Cancer Vaccine Data at SITC 2026

CK Life Sciences subsidiary Sequencio Therapeutics will present new research data from its primary cancer vaccine programmes at the Society for Immunotherapy of Cancer 2026 meeting

  • Sequencio Therapeutics abstracts selected for SITC 2026 meeting
  • hTROP2 circRNA-LNP vaccine study shows increased T-cell subsets
  • PD-L1/PRAME dual-antigen vaccine inhibits tumor growth in mice

More from Thursday 5 November →